Dishman Carbogen AmicsNSE:DCAL +4.03%71 Days Payable is 142.84 as of Mar. 2026, which is 8% below its 10-year median of 154.87. GuruFocus rates NSE:DCAL with a GF Score™ of 71/100 and a GF Value™ of ₹237.00 (Modestly Undervalued). The stock has 3 warning signs investors should review. Among 704 Biotechnology companies, Dishman Carbogen Amics ranks better than 62.93% on this metric.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
NSE:DCAL vs VRTX, REGN, ALNY: Days Payable Comparison
For the Biotechnology subindustry, Dishman Carbogen Amics's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Dishman Carbogen Amics Days Payable vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Dishman Carbogen Amics's Days Payable distribution charts can be found below:
* The bar in red indicates where Dishman Carbogen Amics's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
Dishman Carbogen Amics's Days Payable for the fiscal year that ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Dishman Carbogen Amics (NSE:DCAL) has a Days Payable of 142.84 as of Mar. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Dishman Carbogen Amics and its competitors. This is near median its historical median of 154.87. Over the past decade, Dishman Carbogen Amics' Days Payable has ranged from 93.32 to 209.56. According to the industry distribution chart, Dishman Carbogen Amics ranks #261 out of 704 companies in the Biotechnology industry, placing it in the top 37.1%.
Is Dishman Carbogen Amics' Days Payable too high?
Dishman Carbogen Amics' current Days Payable of 142.84 is near median its 10-year median of 154.87. Over the past 10 years, this metric has ranged from a low of 93.32 to a high of 209.56. The Biotechnology industry median Days Payable is 113.56. Dishman Carbogen Amics' value of 142.84 is 25.8% above this industry median. Based on the distribution chart, Dishman Carbogen Amics ranks #261 out of 704 companies in the Biotechnology industry, which is above the industry midpoint. Overall, Dishman Carbogen Amics has a GF Score™ of 71/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Dishman Carbogen Amics' Days Payable compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Dishman Carbogen Amics ranks #261 out of 704 companies for Days Payable. This puts Dishman Carbogen Amics in the upper half of its industry. The industry median Days Payable is 113.56. Dishman Carbogen Amics' value of 142.84 is 25.8% above this benchmark. Historically, Dishman Carbogen Amics' own Days Payable has ranged from 93.32 to 209.56 over the past decade. While the company's 10-year median is 154.87 vs. the industry median of 113.56, Dishman Carbogen Amics has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Biotechnology company?
The median Days Payable among Biotechnology companies is 113.56, based on 704 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Dishman Carbogen Amics's current Days Payable of 142.84 is 25.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Dishman Carbogen Amics and its competitors. For the Biotechnology industry, the median Days Payable is 113.56 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Dishman Carbogen Amics's current Days Payable is 142.84, which is near median its own 10-year median of 154.87. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Dishman Carbogen Amics stock overvalued right now?
Based on GuruFocus' analysis, Dishman Carbogen Amics (NSE:DCAL) is currently considered Modestly Undervalued. The stock's GF Value™ is ₹237.00, compared to a current price of ₹175.37 — trading 26% below its estimated fair value. The current Days Payable is 142.84, which is near median its 10-year median of 154.87 and 25.8% above the Biotechnology industry median of 113.56. Dishman Carbogen Amics' overall GF Score™ is 71/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Dishman Carbogen Amics (NSE:DCAL), the current Days Payable is 142.84 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Dishman Carbogen Amics (NSE:DCAL) Overvalued in 2026?
Based on GuruFocus' analysis, Dishman Carbogen Amics stock appears to be undervalued.
The current stock price of ₹175.37 is trading 26% below its estimated GF Value™ of ₹237.00.
GuruFocus considers Dishman Carbogen Amics to be Modestly Undervalued.
Key valuation signals for NSE:DCAL:
Days Payable: 142.84 (near median its 10-year median of 154.87)
GF Value™: ₹237.00 vs. price of ₹175.37 (26% below fair value)
Industry Position: 25.8% above the Biotechnology median (#261 of 704)
No single metric tells the full story. See the NSE:DCAL stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Dishman Carbogen Amics Ltd is a biotechnology company that provides contract research and manufacturing services for pharmaceutical companies. It manufactures bulk drugs, specialty chemicals, and outsourced goods. Additionally, the company produces vitamins, such as vitamin D2 and vitamin D3, reagents, antiseptics and disinfectants, transfer catalysts, personal-care ingredients, pharma intermediates, and ammonium and phosphonium high-purity solid Quats. The business generates the vast majority of its revenue in India.
71GF Score
Get the complete analysis for NSE:DCAL
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:DCAL has been successfully added to your 
